Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abhilasha Pharma is a private Indian pharmaceutical manufacturing company focused on active pharmaceutical ingredients (APIs), bulk drugs, and pharmaceutical intermediates. The company operates a cGMP-compliant manufacturing facility in Ankleshwar, Gujarat, and markets itself as supplying APIs and intermediates to other pharmaceutical companies rather than developing novel therapeutics. Its disclosed product portfolio includes commercial and developing small-molecule APIs such as metformin hydrochloride, pioglitazone hydrochloride, nebivolol hydrochloride, loratadine, desloratadine, chlorhexidine derivatives, clopidogrel bisulphate, dapoxetine, and nitazoxanide. Abhilasha Pharma also highlights in-house quality control capabilities and regulatory/technical documentation support such as DMF and technical packages for selected products. Overall, it appears to be a commercial-stage pharma manufacturer/CDMO-style supplier serving formulation and pharmaceutical manufacturing customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abhilasha Pharma.